HK1201283A1 - Influenza c virus and vaccine - Google Patents

Influenza c virus and vaccine Download PDF

Info

Publication number
HK1201283A1
HK1201283A1 HK15101817.2A HK15101817A HK1201283A1 HK 1201283 A1 HK1201283 A1 HK 1201283A1 HK 15101817 A HK15101817 A HK 15101817A HK 1201283 A1 HK1201283 A1 HK 1201283A1
Authority
HK
Hong Kong
Prior art keywords
virus
influenza
pigs
studies
humans
Prior art date
Application number
HK15101817.2A
Other languages
English (en)
Chinese (zh)
Inventor
R. Simonson Randy
A. Collin Emily
M. Hause Benjamin
Original Assignee
Newport Laboratories, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Newport Laboratories, Inc. filed Critical Newport Laboratories, Inc.
Publication of HK1201283A1 publication Critical patent/HK1201283A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16311—Influenzavirus C, i.e. influenza C virus
    • C12N2760/16321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16311—Influenzavirus C, i.e. influenza C virus
    • C12N2760/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16311—Influenzavirus C, i.e. influenza C virus
    • C12N2760/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HK15101817.2A 2012-01-27 2013-01-28 Influenza c virus and vaccine HK1201283A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/385,004 2012-01-27
US13/385,004 US9278999B2 (en) 2012-01-27 2012-01-27 Influenza C virus and vaccine
PCT/US2013/023441 WO2013112995A1 (en) 2012-01-27 2013-01-28 Influenza c virus and vaccine

Publications (1)

Publication Number Publication Date
HK1201283A1 true HK1201283A1 (en) 2015-08-28

Family

ID=47714564

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15101817.2A HK1201283A1 (en) 2012-01-27 2013-01-28 Influenza c virus and vaccine

Country Status (13)

Country Link
US (1) US9278999B2 (enExample)
EP (1) EP2807184A1 (enExample)
JP (1) JP6257529B2 (enExample)
CN (1) CN104203972A (enExample)
AU (1) AU2013211833B2 (enExample)
BR (1) BR112014018278B1 (enExample)
CA (1) CA2862328C (enExample)
HK (1) HK1201283A1 (enExample)
MX (1) MX360831B (enExample)
NZ (1) NZ629378A (enExample)
PH (1) PH12014501688A1 (enExample)
RU (1) RU2656186C2 (enExample)
WO (1) WO2013112995A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2015000789A (es) * 2012-07-19 2015-05-07 Zoetis Llc Composiciones de virus de la gripe bovina.
AR111770A1 (es) 2017-05-05 2019-08-21 Elanco Us Inc Vacuna para enfermedad respiratoria bovina
CN111363855A (zh) * 2020-04-30 2020-07-03 山东省农业科学院家禽研究所（山东省无特定病原鸡研究中心） 一种同时检测a、d型流感病毒的成套试剂、试剂盒及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004161781A (ja) * 1992-03-03 2004-06-10 Dai Ichi Seiyaku Co Ltd 経口ワクチン
AUPQ846900A0 (en) * 2000-06-29 2000-07-27 Aruba International Pty Ltd A vaccine
CA2671869A1 (en) * 2006-12-15 2008-06-26 Schering-Plough Ltd. Method for replicating influenza virus in culture
TW200927928A (en) 2007-09-24 2009-07-01 Nobilon Internat B V Inactivated influenza vaccine
US20090110698A1 (en) * 2007-10-31 2009-04-30 Newport Laboratories, Inc. Method of determining vaccine compliance
RU2428476C1 (ru) * 2010-06-21 2011-09-10 Учреждение Российской Академии Медицинских Наук Научно-исследовательский институт экспериментальной медицины Северо-западного отделения РАМН (НИИЭМ СЗО РАМН) Реассортантный штамм вируса гриппа rn 1/09-swine a(h7n1) для определения антител к нейраминидазе при гриппозной инфекции и вакцинации

Also Published As

Publication number Publication date
JP2015506949A (ja) 2015-03-05
AU2013211833A1 (en) 2014-09-18
CN104203972A (zh) 2014-12-10
BR112014018278A2 (pt) 2019-04-02
US20130195915A1 (en) 2013-08-01
AU2013211833B2 (en) 2017-09-14
RU2656186C2 (ru) 2018-05-31
CA2862328C (en) 2021-08-31
PH12014501688A1 (en) 2014-10-20
NZ629378A (en) 2017-06-30
CA2862328A1 (en) 2013-08-01
RU2014134850A (ru) 2016-03-20
BR112014018278B1 (pt) 2023-01-17
WO2013112995A1 (en) 2013-08-01
US9278999B2 (en) 2016-03-08
EP2807184A1 (en) 2014-12-03
MX360831B (es) 2018-11-16
JP6257529B2 (ja) 2018-01-10
MX2014009022A (es) 2015-03-03
AU2013211833A2 (en) 2014-09-25

Similar Documents

Publication Publication Date Title
WO2011103453A3 (en) Vaccines for use in the prophylaxis and treatment of influenza virus disease
WO2017070626A3 (en) Respiratory virus vaccines
WO2016019134A8 (en) Flagellin-based agents and uses including effective vaccination
MX343048B (es) Oligodesoxinucleotidos inmunoestimulantes.
MX340830B (es) Vacuna neumococica y usos de la misma.
WO2008039267A3 (en) Inducing cellular immune responses to influenza virus using peptide and nucleic acid compositions
MX352604B (es) Composiciones inmunogenicas de la glucoproteina g de los virus hendra y nipah.
BR112014033046A2 (pt) linhagem mutante atenuada de salmonella typhi, vacina de dna e vacina de dna vxm01
MX2013013800A (es) Oligodesoxinucleotidos inmunoestimuladores.
MX2013013801A (es) Oligodesoxinucleotidos inmunoestimuladores.
WO2013106689A8 (en) Hcv ns3 protease inhibitors
WO2011094363A3 (en) Influenza virus compositions and methods for universal vaccines
PH12018000197A1 (en) Hand, foot, and mouth vaccines and methods of manufacture and use thereof
NZ731659A (en) Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus
PH12015501378A1 (en) Porcine parvovirus 5a, methods of use and vaccine
EA201500140A1 (ru) Ослабленные вакцины от свиного гриппа и способы их получения и применения
WO2016100615A3 (en) Methods and composition for neutralization of influenza
EA201400235A1 (ru) Вакцины против гриппа на основе н5
PH12015501721A1 (en) Porcine parvovirus 5b, methods of use and vaccine
WO2011112906A3 (en) Novel immunogens and methods for discovery and screening thereof
WO2014140166A3 (en) Vaccine
HK1201283A1 (en) Influenza c virus and vaccine
WO2014167582A3 (en) Vaccine composition for prophylaxis in ruminants
GB2515222A (en) Use of flagellin as a vaccine
MX2016002903A (es) Composiciones inmunogenas de la glicoproteina g de los virus hendra y nipah.